A new trend, fueled by social media, involves people taking Ozempic (semaglutide) in tiny doses, a practice dubbed microdosing. The purpose of Ozempic microdosing is to lose weight or curb appetite without the typical side effects or costs of full doses. On platforms like TikTok (using hashtags such as #GLP1Hack), Reddit, and Facebook, users share anecdotes of weight loss from taking just a fraction of the standard Ozempic dose. However, medical experts from leading institutions (including UCLA Health and the Mayo Clinic) are sounding caution. They emphasize that microdosing Ozempic is an experimental, unauthorized practice with no clinical guidance or evidence of safety and effectiveness. We are looking for doctors, healthcare professionals, clinical weight loss experts, and anyone with credentials suitable to answer or comment on the following areas: Why are people microdosing Ozempic? Social media’s role in Ozempic microdosing Is it safe? What are the risks (long and short-term)? The dangers of off-brand GLP-1 agonists Broader concerns

posted5/15/2025

deadline5/19/2025

processing

published